Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited)

v3.23.2
Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Shares
Additional Paid-in Capital
Warrants
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Non-Controlling Interest
Total
Balance at beginning of period at Dec. 31, 2021 $ 854,952 $ 224,835 $ 952 $ 999 $ (856,248) $ 175 $ 225,665
Balance at beginning of period (in shares) at Dec. 31, 2021 374,082,759            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Share-based compensation   81         81
Issuance and vesting (forfeiture) of restricted share units $ 888           888
Issuance and vesting (forfeiture) of restricted share units (in shares) 1,220,468            
Shares reserved for contingent consideration $ 257           257
Comprehensive income (loss) for the period       1 (11,629) (5) (11,633)
Balance at end of the period at Mar. 31, 2022 $ 856,097 224,916 952 1,000 (867,877) 170 215,258
Balance at end of period (in shares) at Mar. 31, 2022 375,303,227            
Balance at beginning of period at Dec. 31, 2021 $ 854,952 224,835 952 999 (856,248) 175 225,665
Balance at beginning of period (in shares) at Dec. 31, 2021 374,082,759            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Comprehensive income (loss) for the period             (18,690)
Balance at end of the period at Jun. 30, 2022 $ 856,866 224,934 952 997 (874,928) 167 208,988
Balance at end of period (in shares) at Jun. 30, 2022 375,776,275            
Balance at beginning of period at Mar. 31, 2022 $ 856,097 224,916 952 1,000 (867,877) 170 215,258
Balance at beginning of period (in shares) at Mar. 31, 2022 375,303,227            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Share-based compensation   18         18
Issuance and vesting (forfeiture) of restricted share units $ 508           508
Issuance and vesting (forfeiture) of restricted share units (in shares) 473,048            
Shares reserved for contingent consideration $ 261           261
Comprehensive income (loss) for the period       (3) (7,051) (3) (7,057)
Balance at end of the period at Jun. 30, 2022 $ 856,866 224,934 952 997 (874,928) 167 208,988
Balance at end of period (in shares) at Jun. 30, 2022 375,776,275            
Balance at beginning of period at Dec. 31, 2022 $ 858,143 225,127 796 988 (963,703) 166 121,517
Balance at beginning of period (in shares) at Dec. 31, 2022 377,515,391            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Share-based compensation   31         31
Warrants expired   67 (67)        
Issuance and vesting (forfeiture) of restricted share units $ 209           209
Issuance and vesting (forfeiture) of restricted share units (in shares) 370,744            
Shares reserved for contingent consideration $ 53           53
Warrants issued as part of debt modification     5,106       5,106
Comprehensive income (loss) for the period       (2) (4,875) 9 (4,868)
Balance at end of the period at Mar. 31, 2023 $ 858,405 225,225 5,835 986 (968,578) 175 122,048
Balance at end of period (in shares) at Mar. 31, 2023 377,886,135            
Balance at beginning of period at Dec. 31, 2022 $ 858,143 225,127 796 988 (963,703) 166 121,517
Balance at beginning of period (in shares) at Dec. 31, 2022 377,515,391            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Comprehensive income (loss) for the period             (33,208)
Balance at end of the period at Jun. 30, 2023 $ 856,044 225,228 5,835 983 (995,473) (1,267) 91,350
Balance at end of period (in shares) at Jun. 30, 2023 378,528,861            
Balance at beginning of period at Mar. 31, 2023 $ 858,405 225,225 5,835 986 (968,578) 175 122,048
Balance at beginning of period (in shares) at Mar. 31, 2023 377,886,135            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Share-based compensation   3         3
Issuance and vesting (forfeiture) of restricted share units $ (1,074)           (1,074)
Issuance and vesting (forfeiture) of restricted share units (in shares) 642,726            
Shares reserved for contingent consideration $ (1,287)           (1,287)
Comprehensive income (loss) for the period       (3) (26,895) (1,442) (28,340)
Balance at end of the period at Jun. 30, 2023 $ 856,044 $ 225,228 $ 5,835 $ 983 $ (995,473) $ (1,267) $ 91,350
Balance at end of period (in shares) at Jun. 30, 2023 378,528,861